Children with asthma were studied during the Southern hemisphere winter and summer of 2001-2002. Human rhinovirus (hRV) was significantly associated ( ) with P p .0001 asthma exacerbations in winter and spring/summer, but not in intervening asymptomatic periods. Although hRV was also found in children with upper respiratory tract infection (URTI) who underwent sampling at the same time, it was present in significantly higher numbers of children with symptomatic asthma ( ). Human metapneumovirus P ! .0001 was also found in small numbers of children with URTI, but significantly less frequently in children with asthma. Viral infections, with human rhinoviruses (hRVs) in particular, cause ∼60% of all upper respiratory tract (URT) infections (URTIs) [1] . Most children have been exposed to respiratory viruses by an early age; up to 40% of infants !2 weeks old have been exposed [2] . Furthermore, ∼80% of childhood asthma exacerbations are associated with viruses [3] , and the majority of such exacerbations are due to hRV infection [4, 5] . Studies show a correlation among clinical presentation with a URTI, virus detection in the lower respiratory tract (LRT) or URT
Viral infections, with human rhinoviruses (hRVs) in particular, cause ∼60% of all upper respiratory tract (URT) infections (URTIs) [1] . Most children have been exposed to respiratory viruses by an early age; up to 40% of infants !2 weeks old have been exposed [2] . Furthermore, ∼80% of childhood asthma exacerbations are associated with viruses [3] , and the majority of such exacerbations are due to hRV infection [4, 5] . Studies show a correlation among clinical presentation with a URTI, virus detection in the lower respiratory tract (LRT) or URT [5] , and the occurrence of asthma [6] . However, hRVs are also found in up to 12% of completely asymptomatic adolescents, which suggests that infection can occur without symptomatic disease in some individuals [7] . The demonstration of any virus as an etiological agent either in causation or exacerbation of childhood asthma is further complicated by the increased detection of viruses, which is a result of the increased sensitivity of nucleic acid amplification techniques over previous culture techniques [1] . An etiological role for viruses in asthma exacerbations is suggested by epidemiological studies demonstrating that seasonal patterns of URTI correlate with hospital admissions for childhood asthma [7] , as shown by the association between clinical presentation with URTIs, detection of viruses (particularly hRV) and asthma exacerbations [5] , and the presence of viruses (particularly hRVs and coronaviruses) in the LRT [1, 4] .
The pathogenesis of clinical asthma developing in response to viral infection of the LRT may be related in part to the predominance of Th2-type immune responses to viral infections in children with asthma [6] . Viruses, including hRV, have been shown to alter neural control of the airway, produce increased sensitivity of the LRT to nonspecific stimuli, increase airways inflammation, increase variable airway obstruction, and affect the structure of small airways, which results in narrowing, air-trapping, and ventilation-perfusion mismatches [4, 6, 7] . There is evidence for synergy between these changes induced by hRV infection and the presence of atopy in adults and children [4] . Experimental studies have also demonstrated inflammatory responses that would be consistent with asthma exacerbations in experimental subjects [8] and in model systems. The effects of viral infection may differ according to the age at which the child is infected [9] , the associated allergens, the variability in host response [4] , and the existence of previous viral infections [4] . Although studies have concentrated on hRV infection, other agents (e.g., Chlamydia pneumoniae, Mycoplasma pneumoniae [10] , and bacteria) have been associated with asthma exacerbations.
The presence of different receptors for different hRV serotypes (90% use intercellular adhesion molecule 1, and others use the low-density lipoprotein receptor) further complicates assessment of URTI and LRT infection (LRTI), in which multiple serotypes may infect one individual [11, 12] . Asthmatic changes in airway smooth muscle may not necessarily depend on viral replication, because smooth-muscle hyperresponsiveness has been shown to occur after inoculation with nonreplicating (UV irradiated) hRV of only certain subtypes (i.e., ) vs. children with asymptomatic asthma (2-sided Fisher's exact test). P p .0001 n p 29 e Sixty-two of 71 samples were tested. There was insufficient specimen available for testing for the remaining 9 samples. hRV16) [13] . Furthermore, the quantity of virus has not been useful in determining the risk of asthma exacerbations in children [4] .
We tested the hypothesis that viral infections are associated with asthma exacerbations by assessing nasopharyngeal aspirate is reflected in overall modal and median ages of 0.2 and 1 year, respectively, for children with URTI and 1.7 and 2.5 years, respectively, for children with asthma (table 1 ). An exacerbation of asthma was defined according to standard Australian criteria, which are based in part on 1997 guidelines of the US National Heart, Lung, and Blood Institute [14] (i.e., evidence of cough, wheeze, and breathlessness, with airways obstruction that was reversed with bronchodilator use; table 2). URTI was defined as the presence of rhinorrhoea and/or sore throat without major systemic illness, with or without other objective signs of infection (e.g., fever, lymphadenopathy, or pharyngitis), in the absence of wheeze, dyspnea, crepitations, and bronchodilator use. NPA samples were taken from children with URTI for diagnosis and to rule out significant treatable pathogens. NPA samples were tested for adenovirus, influenza virus A, influenza virus B, parainfluenzavirus 1, 2, and 3, and respiratory syncytial virus (RSV) by use of direct immunofluorescence (Bartels); for hRV by use of polymerase chain reaction (PCR) with genus-specific primers [15] ; and for hMPV by use of PCR with specific primers [16] . Specimens were also analyzed for other viruses and bacteria using standard diagnostic culture techniques [17] . Culture for respiratory viruses was performed with MadinDarby canine kidney cells in a shell vial incubated for 4-6 days and by standard viral culture in diploid human fibroblasts (MRC-5) and rhesus monkey kidney (LLCMK2) cells [16] . All PCRs were performed using positive controls, negative controls, and standard precautions to prevent contamination.
RNA was extracted from all samples using QIAamp viral RNA kits and was reverse-transcribed using OneStep reversetranscriptase (RT) PCR kits (both from Qiagen). hMPV was detected using 5 mL of the extracted NPA RNA and was amplified using L6 (nucleotide position 11336-11357) and L7 (nucleotide position 11506-11486) primers derived from the conserved region of the L gene [16] . After initial heating at 50ЊC for 30 min and 94ЊC for 15 min, there were 35 cycles of denaturation (45 s at 94ЊC), annealing (45 s at 58ЊC), and extension (45 s at 72ЊC), followed by a final hold at 72ЊC for 10 min. The product then was subjected to electrophoresis in a 2% agarose gel. hRV was detected using 10 mL of the extracted RNA and amplified using P1 primers to produce a 106-bp amplicon [15] . For the master mix, Qiagen OneStep RT-PCR kits were used, and 0.4 mL of dig-11-dUTP was added to each reaction tube. After initial heating at 50ЊC for 30 min and 94ЊC for 15 min, 40 cycles of denaturation (45 s at 94ЊC), annealing (45 s at 55ЊC), and extension (8 s at 72ЊC) were performed, followed by a final hold at 72ЊC for 10 min. The product was subjected to electrophoresis in a 3% agarose gel. The hRV amplicons were detected using a novel degenerate internal probe (5 -GTC GTA AYG AGC AAY TGY GGG A-3 ) and the PCR-ELISA DIG-Detection kit (Roche Diagnostics). The ELISA de-tected amplicons with a 10-fold greater sensitivity than did the agarose gel detection methods, although both were performed (data not shown). Enteroviruses (EVs) were detected by use of methods published elsewhere [18] . Statistical significance for difference in incidence of viral infection was tested using a 2-sided Fisher's exact test, and relative risk was calculated using SPSS software (version 6.1; SPSS) .
Results. The results show that hMPV and, in particular, hRV cause large numbers of respiratory tract infections in children with URTI and asthma (table 1). The children with RSV were predominantly !2 years old (19/20 children), which is consistent with other studies showing that RSV infection is common before the age of 2 years [5] . Significantly larger numbers of children with URTI were infected with hMPV, although the overall infection rate during winter and summer was low (maximum, 16% in summer 2001). Infection with hRV was more common, causing 50% of the URTIs during all time periods sampled. Coinfection was reasonably common in this group of children, particularly during the winter and especially with RSV (table 1) . Children with symptomatic asthma had significantly higher rates of infection with hRV (79% vs. 52% among all children), and coinfection with another respiratory virus was relatively uncommon, except for the summer 2002 period (table 1) . Children with asthma who were asymptomatic and were sampled at the time of routine review had significantly lower rates of hRV carriage than did children with symptomatic asthma (17% vs. 79%). This difference remained highly significant even when these 2 groups were compared as totals, were age-matched, or were temporarily matched for presentation. hRV infection was significantly associated with exacerbations of asthma, compared with children with URTI (P ! ) or with samples taken from children with asthma during .0001 asymptomatic periods ( ). The rate of asymptomatic P ! .0001 carriage of hRV in children with asthma during the summer (17%) reflects the sensitive nature of the tests used [15] , although EVs, which are commonly found in the URT, were present at much lower rates, despite similarly sensitive methods being used [18] .
Discussion. The data presented here indicate that, during winter and during the seasonal peak of asthma exacerbations, children without asthma are developing URTI due to hRV (which is known [1, 3] ) and hMPV, as shown in the northern hemisphere [16] . However, children with asthma who developed acute exacerbations during winter and during the seasonal peak in spring/summer had hRV present in their URT in 2 consecutive years at much greater rates than did children with URTI (79% vs. 52%), but they had hMPV at significantly lower rates (2% vs. 6%) than did children with URTI ( ) and P ! .001 children in previous studies [16] .
Because some viruses (i.e., hRV) are associated with asthma but others are not (i.e., hMPV and EV), it is possible that there are virus-specific receptors that allow particular viruses, such as hRV, to cause LRT attachment and bronchial smooth-muscle contraction [8] , which results in symptomatic bronchial constriction and asthma. Viral infection per se is not always sufficient to cause bronchial smooth-muscle contraction in model systems, and infection with particular genotypes/serotypes of some viruses may be required [8, 13] . These observations are only of clinical relevance if hRV reaches the bronchial smooth muscle in the LRT or releases local or systemic mediators that mediate bronchial smooth-muscle contraction. The role of URTI versus LRTI needs to be investigated, because, increasingly, the use of sensitive methods to sample viruses (PCR in the current study) indicate that viral respiratory tract infection is common in the URT. The net result of increased sensitivity of nucleic-acid testing is that larger numbers of symptomatic and asymptomatic, infected individuals are identified in the present study (table 1) and previous studies [4, 5] . This increased sensitivity must be considered when comparing recent studies with those performed previously and means that the choice of control groups is critical. The presence of hRV RNA in NPA samples from 17% of asymptomatic children with known asthma reflects this increased sensitivity, because all these children were clinically well and culture negative. It needs to be determined whether quantity of virus, viral genotype, location of virus (URT vs. LRT), infection with multiple species, or a combination of these factors are important in determining whether viral infection at a given time results in exacerbation of asthma. Multiple viral infection was common among children with URTI in winter but not among children with asthma; therefore, we could not test the hypothesis that more-severe asthma exacerbations could result from infection with multiple viruses. Overall, there is evidence from this work that more-sensitive techniques detect hRV in the URT of significantly greater numbers of children with asthmas during wheezing exacerbations than during interillness periods and in more children with asthmas during exacerbations than in children without asthma with URTI, which is consistent with results of previous studies [2, 4, 5] . Furthermore, results of NPA sampling for 2 years during the peak period of childhood asthmatic exacerbations (spring/ summer) and winter in Australia suggest that infection with a single agent (hRV) is sufficient to cause exacerbations of asthma in children (table 1) . This suggests that therapeutic interventions directed toward hRV may reduce or prevent some asthmatic exacerbations in susceptible individuals.
